THU0145 A multi-biomarker disease activity (MBDA) score measures rheumatoid arthritis disease activity in patients treated with the JAK inhibitor tofacitinib

K. Yamaoka; S. Kubo; K. Sonomoto; S. Hirata; A. Voinov; M. Rowe; G. Cavet; K. Saito; Y. Tanaka

doi:10.1136/annrheumdis-2012-eular.2110

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Scientific Abstracts

Poster Presentations

Posters

Rheumatoid arthritis – non-biologic treatment and small molecules

THU0145 A multi-biomarker disease activity (MBDA) score measures rheumatoid arthritis disease activity in patients treated with the JAK inhibitor tofacitinib

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Yamaoka K, Kubo S, Sonomoto K, et al

THU0145 A multi-biomarker disease activity (MBDA) score measures rheumatoid arthritis disease activity in patients treated with the JAK inhibitor tofacitinib

Annals of the Rheumatic Diseases 2013;71:204.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password